Terumo Corp (4543):企業の製品パイプライン分析2018

◆英語タイトル:Terumo Corp (4543) - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C8810
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:103
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥162,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥243,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include vascular interventional products, cardiovascular surgical systems, artificial vascular grafts, blood transfusion systems, infusion systems, nutritious food, diabetes monitoring and treatment devices, cancer pain management systems, home oxygen therapy systems and consumer healthcare products. The company’s systems find application in and interventional therapies performed inside blood vessels and cardiac and vascular surgery. Terumo also operates blood centers for collecting blood and processing for addressing the transfusion requirement of patients. The company operates through its subsidiaries and associate companies in Japan, China, Europe, North America, South America, and Asia (excluding China and Japan). Terumo is headquartered in Tokyo, Japan.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Terumo Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Terumo Corp Company Overview 8
Terumo Corp Company Snapshot 8
Terumo Corp Pipeline Products and Ongoing Clinical Trials Overview 8
Terumo Corp – Pipeline Analysis Overview 11
Business Description 11
Terumo Corp – Key Facts 11
Terumo Corp – Major Products and Services 12
Terumo Corp Pipeline Products by Development Stage 14
Terumo Corp Ongoing Clinical Trials by Trial Status 21
Terumo Corp Pipeline Products Overview 24
Access Device For Infusion 24
Access Device For Infusion Product Overview 24
Advanced Coil 25
Advanced Coil Product Overview 25
Advanced WEB Aneurysm Embolization Device 26
Advanced WEB Aneurysm Embolization Device Product Overview 26
Advanced WEB Aneurysm Embolization Device Clinical Trial 27
Atherectomy Device 28
Atherectomy Device Product Overview 28
Cardiovascular Imaging System 29
Cardiovascular Imaging System Product Overview 29
CDI Inline Blood Gas Monitoring System 30
CDI Inline Blood Gas Monitoring System Product Overview 30
CMOS Image Glucose Sensor 31
CMOS Image Glucose Sensor Product Overview 31
Coated Stent 32
Coated Stent Product Overview 32
DuraHeart Destination Therapy Left Ventricular Assist System 33
DuraHeart Destination Therapy Left Ventricular Assist System Product Overview 33
ERIC Retrieval Device 34
ERIC Retrieval Device Product Overview 34
Flash PTCA 35
Flash PTCA Product Overview 35
FRED Flow-Diverting Stent 36
FRED Flow-Diverting Stent Product Overview 36
FRED Flow-Diverting Stent Clinical Trial 37
High Accuracy CGM 38
High Accuracy CGM Product Overview 38
IVUS 39
IVUS Product Overview 39
Large Volume Injector 40
Large Volume Injector Product Overview 40
Liver Cancer Ablation System 41
Liver Cancer Ablation System Product Overview 41
Mirasol Pathogen Reduction Technology System – Platelets 42
Mirasol Pathogen Reduction Technology System – Platelets Product Overview 42
Mirasol Pathogen Reduction Technology System – Platelets Clinical Trial 43
Mirasol Pathogen Reduction Technology System – Whole Blood 44
Mirasol Pathogen Reduction Technology System – Whole Blood Product Overview 44
Mirasol Pathogen Reduction Technology System – Whole Blood Clinical Trial 45
Next Generation Anaconda LP Stent Graft 46
Next Generation Anaconda LP Stent Graft Product Overview 46
Next Generation Drug Eluting Bioresorbable Scaffold 47
Next Generation Drug Eluting Bioresorbable Scaffold Product Overview 47
Next Generation Drug Eluting Stent – Complex Lesion 48
Next Generation Drug Eluting Stent – Complex Lesion Product Overview 48
Next Generation Oxygenator NX 49
Next Generation Oxygenator NX Product Overview 49
Next Generation SmartPump 50
Next Generation SmartPump Product Overview 50
Next Metallic Drug Eluting Stent 51
Next Metallic Drug Eluting Stent Product Overview 51
Ophthalmic Needle 52
Ophthalmic Needle Product Overview 52
Peripheral Therapeutic Device 53
Peripheral Therapeutic Device Product Overview 53
PLAJEX With FKB327 54
PLAJEX With FKB327 Product Overview 54
PLAJEX With Tapered Needle 55
PLAJEX With Tapered Needle Product Overview 55
Plastic Needle 56
Plastic Needle Product Overview 56
Relay NBS Plus 57
Relay NBS Plus Product Overview 57
Relay Thoracic Stent Graft With Plus Delivery System 58
Relay Thoracic Stent Graft With Plus Delivery System Product Overview 58
RelayBranch Thoracic Stent-Graft System 59
RelayBranch Thoracic Stent-Graft System Product Overview 59
RelayBranch Thoracic Stent-Graft System Clinical Trial 60
RelayPro Thoracic Stent-Graft System – Acute Complicated Type B Thoracic Aortic Dissection 61
RelayPro Thoracic Stent-Graft System – Acute Complicated Type B Thoracic Aortic Dissection Product Overview 61
RelayPro Thoracic Stent-Graft System – Acute Complicated Type B Thoracic Aortic Dissection Clinical Trial 62
RelayPro Thoracic Stent-Graft System – Blunt Traumatic Aortic Injury 63
RelayPro Thoracic Stent-Graft System – Blunt Traumatic Aortic Injury Product Overview 63
RelayPro Thoracic Stent-Graft System – Descending Thoracic Aortic Aneurysms 64
RelayPro Thoracic Stent-Graft System – Descending Thoracic Aortic Aneurysms Product Overview 64
RelayPro Thoracic Stent-Graft System – Descending Thoracic Aortic Aneurysms Clinical Trial 65
Renal Sympathetic Denervation System – TRI Technique 66
Renal Sympathetic Denervation System – TRI Technique Product Overview 66
Runner PTCA Balloon Catheter 67
Runner PTCA Balloon Catheter Product Overview 67
Runner Slim PTCA 68
Runner Slim PTCA Product Overview 68
Sofia Ex 69
Sofia Ex Product Overview 69
Therapeutic Apheresis System 70
Therapeutic Apheresis System Product Overview 70
Thoraflex Hybrid 71
Thoraflex Hybrid Product Overview 71
Thoraflex Hybrid Clinical Trial 72
TREO Abdominal Stent-Graft System 73
TREO Abdominal Stent-Graft System Product Overview 73
TREO Abdominal Stent-Graft System Clinical Trial 74
TREO Aorto-Uni-Iliac Abdominal Stent-Graft System 75
TREO Aorto-Uni-Iliac Abdominal Stent-Graft System Product Overview 75
TREO Aorto-Uni-Iliac Abdominal Stent-Graft System Clinical Trial 76
Treovance Abdominal Stent Graft With Navitel Delivery System 77
Treovance Abdominal Stent Graft With Navitel Delivery System Product Overview 77
Treovance Abdominal Stent Graft With Navitel Delivery System Clinical Trial 78
TRI PTA Balloon 79
TRI PTA Balloon Product Overview 79
TRI PTA Guiding Sheath 80
TRI PTA Guiding Sheath Product Overview 80
TRI Stent 81
TRI Stent Product Overview 81
Triplex Advanced Vascular Graft 82
Triplex Advanced Vascular Graft Product Overview 82
Ultimaster Tansei 83
Ultimaster Tansei Product Overview 83
WEB Aneurysm Embolization System 84
WEB Aneurysm Embolization System Product Overview 84
WEB Aneurysm Embolization System Clinical Trial 85
Terumo Corp – Key Competitors 87
Terumo Corp – Key Employees 88
Terumo Corp – Key Employee Biographies 91
Terumo Corp – Locations And Subsidiaries 92
Head Office 92
Other Locations & Subsidiaries 92
Joint Venture 95
Recent Developments 96
Terumo Corp, Recent Developments 96
Jul 09, 2018: Terumo to Increase Production Capacity for Alliance Business Pre-filled Syringes Capital Investment of 7 Billion Yen in Terumo Yamaguchi D&D Corporation 96
Jul 04, 2018: Terumo Announces Shipping Delays for Products from Ashitaka Factory 96
Jun 20, 2018: Terumo Acquires CE Marking for Kanshas Drug Coated Balloon Catheter for Lower Extremities 96
Jun 19, 2018: New Data Demonstrate Clinical Experience with Lifepearl Microspheres in over 300 Hepatocellular Carcinoma Patients 97
Jun 12, 2018: MicroVention Announces FDA Clearance For Thrombectomy Device 97
May 31, 2018: MicroVention Announces FDA Approval for Neuro Stent Device 98
May 24, 2018: Terumo to Launch the Ultimaster Tansei Drug Eluting Stent in Europe 98
May 17, 2018: Mirasol-Treated Platelets Show No Clinical Difference in Reducing Bleeding From Conventional Platelets in Plasma 99
May 11, 2018: Terumo Appoints its U.S. based Subsidiary’s Associate as the Fifth Terumo Fellow 99
May 07, 2018: Terumo Recalls Sarns TCM and TCM II Cooling and Heating Systems and HX2 Temperature Management Systems Due to Revised Cleaning Instructions 100
Appendix 101
Methodology 101
About GlobalData 104
Contact Us 104
Disclaimer 104

List of Tables
Terumo Corp Pipeline Products and Ongoing Clinical Trials Overview 8
Terumo Corp Pipeline Products by Equipment Type 9
Terumo Corp Pipeline Products by Indication 10
Terumo Corp Ongoing Clinical Trials by Trial Status 10
Terumo Corp, Key Facts 11
Terumo Corp, Major Products and Services 12
Terumo Corp Number of Pipeline Products by Development Stage 14
Terumo Corp Pipeline Products Summary by Development Stage 15
Terumo Corp Ongoing Clinical Trials by Trial Status 21
Terumo Corp Ongoing Clinical Trials Summary 22
Access Device For Infusion - Product Status 24
Access Device For Infusion - Product Description 24
Advanced Coil - Product Status 25
Advanced Coil - Product Description 25
Advanced WEB Aneurysm Embolization Device - Product Status 26
Advanced WEB Aneurysm Embolization Device - Product Description 26
Advanced WEB Aneurysm Embolization Device - WEB Intrasaccular Therapy Study China Clinical Trial Protocol 27
Atherectomy Device - Product Status 28
Atherectomy Device - Product Description 28
Cardiovascular Imaging System - Product Status 29
Cardiovascular Imaging System - Product Description 29
CDI Inline Blood Gas Monitoring System - Product Status 30
CDI Inline Blood Gas Monitoring System - Product Description 30
CMOS Image Glucose Sensor - Product Status 31
CMOS Image Glucose Sensor - Product Description 31
Coated Stent - Product Status 32
Coated Stent - Product Description 32
DuraHeart Destination Therapy Left Ventricular Assist System - Product Status 33
DuraHeart Destination Therapy Left Ventricular Assist System - Product Description 33
ERIC Retrieval Device - Product Status 34
ERIC Retrieval Device - Product Description 34
Flash PTCA - Product Status 35
Flash PTCA - Product Description 35
FRED Flow-Diverting Stent - Product Status 36
FRED Flow-Diverting Stent - Product Description 36
FRED Flow-Diverting Stent - Pivotal Study of the MicroVention Flow Re-direction Endoluminal Device (FRED) Stent System in the Treatment of Intracranial Aneurysms 37
High Accuracy CGM - Product Status 38
High Accuracy CGM - Product Description 38
IVUS - Product Status 39
IVUS - Product Description 39
Large Volume Injector - Product Status 40
Large Volume Injector - Product Description 40
Liver Cancer Ablation System - Product Status 41
Liver Cancer Ablation System - Product Description 41
Mirasol Pathogen Reduction Technology System - Platelets - Product Status 42
Mirasol Pathogen Reduction Technology System - Platelets - Product Description 42
Mirasol Pathogen Reduction Technology System - Platelets - Clinical Effectiveness of Conventional Versus Mirasol-treated Apheresis Platelets in Patients with Hypoproliferative Thrombocytopenia 43
Mirasol Pathogen Reduction Technology System - Whole Blood - Product Status 44
Mirasol Pathogen Reduction Technology System - Whole Blood - Product Description 44
Mirasol Pathogen Reduction Technology System - Whole Blood - Evaluate the Efficacy and Safety of RBCs Derived From Mirasol-treated Whole Blood Compared with Conventional RBCs in Patients Requiring Chronic Transfusion Support 45
Next Generation Anaconda LP Stent Graft - Product Status 46
Next Generation Anaconda LP Stent Graft - Product Description 46
Next Generation Drug Eluting Bioresorbable Scaffold - Product Status 47
Next Generation Drug Eluting Bioresorbable Scaffold - Product Description 47
Next Generation Drug Eluting Stent - Complex Lesion - Product Status 48
Next Generation Drug Eluting Stent - Complex Lesion - Product Description 48
Next Generation Oxygenator NX - Product Status 49
Next Generation Oxygenator NX - Product Description 49
Next Generation SmartPump - Product Status 50
Next Generation SmartPump - Product Description 50
Next Metallic Drug Eluting Stent - Product Status 51
Next Metallic Drug Eluting Stent - Product Description 51
Ophthalmic Needle - Product Status 52
Ophthalmic Needle - Product Description 52
Peripheral Therapeutic Device - Product Status 53
Peripheral Therapeutic Device - Product Description 53
PLAJEX With FKB327 - Product Status 54
PLAJEX With FKB327 - Product Description 54
PLAJEX With Tapered Needle - Product Status 55
PLAJEX With Tapered Needle - Product Description 55
Plastic Needle - Product Status 56
Plastic Needle - Product Description 56
Relay NBS Plus - Product Status 57
Relay NBS Plus - Product Description 57
Relay Thoracic Stent Graft With Plus Delivery System - Product Status 58
Relay Thoracic Stent Graft With Plus Delivery System - Product Description 58
RelayBranch Thoracic Stent-Graft System - Product Status 59
RelayBranch Thoracic Stent-Graft System - Product Description 59
RelayBranch Thoracic Stent-Graft System - A Prospective, Multicenter, Non-blinded, Non-randomized Early Feasibility Study of the Relay Branch Thoracic Stent-graft System in Subjects with Thoracic Aortic Pathologies Requiring Treatment Proximal to the Origin of the Innominate Artery 60
RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection - Product Status 61
RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection - Product Description 61
RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection - A Prospective, Multicenter, Non-blinded, Non-randomized Study of the RelayPro Thoracic Stent-graft in Subjects with an Acute, Complicated Type B Aortic Dissection 62
RelayPro Thoracic Stent-Graft System - Blunt Traumatic Aortic Injury - Product Status 63
RelayPro Thoracic Stent-Graft System - Blunt Traumatic Aortic Injury - Product Description 63
RelayPro Thoracic Stent-Graft System - Descending Thoracic Aortic Aneurysms - Product Status 64
RelayPro Thoracic Stent-Graft System - Descending Thoracic Aortic Aneurysms - Product Description 64
RelayPro Thoracic Stent-Graft System - Descending Thoracic Aortic Aneurysms - A Prospective, Multicenter, Non-blinded, Non-randomized Study of the Relay PRO Thoracic Stent-graft in Subjects with Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers 65
RelayPro Thoracic Stent-Graft System - Descending Thoracic Aortic Aneurysms - A Prospective, Multicenter, Non-blinded, Non-randomized Study of the RelayPro Thoracic Stent-graft in Subjects with Traumatic Injury of the Descending Thoracic Aorta 65
Renal Sympathetic Denervation System - TRI Technique - Product Status 66
Renal Sympathetic Denervation System - TRI Technique - Product Description 66
Runner PTCA Balloon Catheter - Product Status 67
Runner PTCA Balloon Catheter - Product Description 67
Runner Slim PTCA - Product Status 68
Runner Slim PTCA - Product Description 68
Sofia Ex - Product Status 69
Sofia Ex - Product Description 69
Therapeutic Apheresis System - Product Status 70
Therapeutic Apheresis System - Product Description 70
Thoraflex Hybrid - Product Status 71
Thoraflex Hybrid - Product Description 71
Thoraflex Hybrid - Evaluation of the Thoraflex Hybrid Device for Use in the Repair or Replacement of the Ascending Aorta, Aortic Arch and Descending Aorta in an Open Surgical Procedure 72
Thoraflex Hybrid - Thoraflex Hybrid Post-Market Study 72
TREO Abdominal Stent-Graft System - Product Status 73
TREO Abdominal Stent-Graft System - Product Description 73
TREO Abdominal Stent-Graft System - An EU Post-approval Registry of the TREO Stent-graft for Patients with Infrarenal Abdominal Aortic Aneurysms 74
TREO Aorto-Uni-Iliac Abdominal Stent-Graft System - Product Status 75
TREO Aorto-Uni-Iliac Abdominal Stent-Graft System - Product Description 75
TREO Aorto-Uni-Iliac Abdominal Stent-Graft System - An EU Post-approval Registry of the TREO Stent-graft for Patients with Infrarenal Abdominal Aortic Aneurysms 76
Treovance Abdominal Stent Graft With Navitel Delivery System - Product Status 77
Treovance Abdominal Stent Graft With Navitel Delivery System - Product Description 77
Treovance Abdominal Stent Graft With Navitel Delivery System - A Phase II Clinical Study of the Safety and Performance of the Treovance Stent-graft with Navitel Delivery System for Patients with Infrarenal Abdominal Aortic Aneurysms 78
TRI PTA Balloon - Product Status 79
TRI PTA Balloon - Product Description 79
TRI PTA Guiding Sheath - Product Status 80
TRI PTA Guiding Sheath - Product Description 80
TRI Stent - Product Status 81
TRI Stent - Product Description 81
Triplex Advanced Vascular Graft - Product Status 82
Triplex Advanced Vascular Graft - Product Description 82
Ultimaster Tansei - Product Status 83
Ultimaster Tansei - Product Description 83
WEB Aneurysm Embolization System - Product Status 84
WEB Aneurysm Embolization System - Product Description 84
WEB Aneurysm Embolization System - Clinical Assessment of Web Device in Ruptured Aneurysms 85
WEB Aneurysm Embolization System - The WEB Intrasaccular Therapy Study (WEB-IT) 85
WEB Aneurysm Embolization System - WEB Clinical Assessment of IntraSaccular Aneurysm Therapy 86
WEB Aneurysm Embolization System - WEB Intrasaccular Therapy Study China Clinical Trial Protocol 86
Terumo Corp, Key Employees 88
Terumo Corp, Key Employee Biographies 91
Terumo Corp, Other Locations 92
Terumo Corp, Subsidiaries 93
Terumo Corp, Joint Venture 95
Glossary 103

List of Figures
Terumo Corp Pipeline Products by Equipment Type 9
Terumo Corp Pipeline Products by Development Stage 14
Terumo Corp Ongoing Clinical Trials by Trial Status 21

★海外企業調査レポート[Terumo Corp (4543):企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Corline Biomedical AB (CLBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Corline Biomedical AB (Corline Biomedical), formerly Corline Systems AB is a manufacturer of heparin based solutions. The company offers heparin based solutions to improve kidney transplantation, and applications in the field of regenerative medicine. Its regentrative medicines include cytop …
  • Alfa Wassermann SpA-製薬・医療分野:企業M&A・提携分析
    Summary Alfa Wassermann SpA (Alfa Wassermann), a subsidiary of AlfaSigma SpA is a pharmaceutical company which produces and distributes drugs for human health. The company provides new discoveries in medicine, biology and genomics. Alfa Wassermann finds solutions for paradox treatment. The company o …
  • Samsung Securities Co., Ltd. (016360):企業の財務・戦略的SWOT分析
    Samsung Securities Co., Ltd. (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Ipsen SA (IPN):企業の財務・戦略的SWOT分析
    Ipsen SA (IPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • China CITIC Bank Corporation Limited:企業のM&A・事業提携・投資動向
    China CITIC Bank Corporation Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China CITIC Bank Corporation Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Aeolus Pharmaceuticals Inc (AOLS)-製薬・医療分野:企業M&A・提携分析
    Summary Aeolus Pharmaceuticals Inc (Aeolus) is a biopharmaceutical company that is developing a platform of new compounds for use in cancer, infectious diseases, central nervous system (CNS) diseases, fibrosis and biodefense. The company’s lead product, AEOL 10150 is a broad catalytic antioxidant pa …
  • IHI Corporation:企業の戦略・SWOT・財務分析
    IHI Corporation - Strategy, SWOT and Corporate Finance Report Summary IHI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Public Joint-Stock Company Commercial Bank Privatbank:企業の戦略・SWOT・財務分析
    Public Joint-Stock Company Commercial Bank Privatbank - Strategy, SWOT and Corporate Finance Report Summary Public Joint-Stock Company Commercial Bank Privatbank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • Cubic Corp (CUB):企業の財務・戦略的SWOT分析
    Cubic Corp (CUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Flynn Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Flynn Pharma Ltd (Flynn Pharma) is a pharmaceutical company that manufactures and markets barbiturate products, and oral and injectable antibiotics. The company’s products include cefuroxime, circadin, distaclor, keflex, medikinet tablets, medikinet XL capsules, nebcin, nizatidine, phenytoin …
  • Grupo Juste SAQF:製薬・医療:M&Aディール及び事業提携情報
    Summary Grupo Juste SAQF (Juste) is a developer and distributor of proprietary medicines and active pharmaceutical ingredients. The company offers oral and injectable radiological contrast media; diatrizoic acid, iothalamic acid, iohexol, iopamidol, iodixanol, MRI contrast agents, dihexazin, and oth …
  • Samsung C&T Corp:企業のM&A・事業提携・投資動向
    Samsung C&T Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Samsung C&T Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • MyCartis NV-医療機器分野:企業M&A・提携分析
    Summary MyCartis NV (MyCartis), formerly Pronota NV is a biomarker analysis solution provider. The company develops multiplexed biomarker solutions through evalution and bio assays technology. It uses technologies such as barcoded microparticles, microfluidic assay cartridges and evalution instrumen …
  • HUP-Zagreb d.d.:企業の戦略・SWOT・財務情報
    HUP-Zagreb d.d. - Strategy, SWOT and Corporate Finance Report Summary HUP-Zagreb d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • DesignMedix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DesignMedix Inc (DesignMedix) is a biotechnology company that develop drugs to overcome drug resistance in multiple diseases such as malaria and diarrhea. The company develops malaria cure drugs, malaria preventive drugs and anti-bacterial drugs. It develops DM1157, a drug candidate that pro …
  • Landis+Gyr AG:企業の戦略的SWOT分析
    Landis+Gyr AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Cooperativa Muratori & Cementisti C.M.C di Ravenna:企業の戦略・SWOT・財務情報
    Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report Summary Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Vallourec SA:戦略・SWOT・企業財務分析
    Vallourec SA - Strategy, SWOT and Corporate Finance Report Summary Vallourec SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ACMAT Corporation:企業の戦略・SWOT・財務情報
    ACMAT Corporation - Strategy, SWOT and Corporate Finance Report Summary ACMAT Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Oglethorpe Power Corporation:発電所・企業SWOT分析
    Oglethorpe Power Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆